• Consensus Rating: Hold
  • Consensus Price Target: $38.00
  • Forecasted Upside: 13.50%
  • Number of Analysts: 7
  • Breakdown:
  • 1 Sell Ratings
  • 5 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$33.48
▼ -0.35 (-1.03%)

This chart shows the closing price for G by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Genpact Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for G and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for G

Analyst Price Target is $38.00
▲ +13.50% Upside Potential
This price target is based on 7 analysts offering 12 month price targets for Genpact in the last 3 months. The average price target is $38.00, with a high forecast of $43.00 and a low forecast of $33.00. The average price target represents a 13.50% upside from the last price of $33.48.

This chart shows the closing price for G for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Hold

The current consensus among 7 contributing investment analysts is to hold stock in Genpact. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 5 hold ratings
  • 1 sell ratings
12/1/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 5 hold ratings
  • 1 sell ratings
3/1/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 5 hold ratings
  • 1 sell ratings
5/30/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 5 hold ratings
  • 1 sell ratings
8/28/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 5 hold ratings
  • 1 sell ratings
11/26/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 5 hold ratings
  • 1 sell ratings
2/24/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 5 hold ratings
  • 1 sell ratings
4/24/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 5 hold ratings
  • 1 sell ratings
5/24/2024

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 5 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/10/2024WedbushReiterated RatingNeutral ➝ Neutral$35.00Low
5/10/2024BMO Capital MarketsLower TargetMarket Perform ➝ Market Perform$39.00 ➝ $38.00Low
5/10/2024Needham & Company LLCReiterated RatingBuy ➝ Buy$40.00Low
4/22/2024CitigroupLower TargetNeutral ➝ Neutral$36.00 ➝ $33.00Low
2/9/2024JPMorgan Chase & Co.Boost TargetUnderweight ➝ Underweight$42.00 ➝ $43.00Low
2/9/2024Needham & Company LLCReiterated RatingBuy ➝ Buy$40.00Low
1/30/2024MizuhoInitiated CoverageNeutral$40.00Low
1/17/2024CitigroupBoost TargetNeutral ➝ Neutral$35.00 ➝ $36.00Low
12/15/2023Robert W. BairdReiterated RatingOutperform ➝ Neutral$38.00Low
11/9/2023Needham & Company LLCLower TargetBuy ➝ Buy$50.00 ➝ $40.00Low
8/22/2023JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight$40.00Low
8/11/2023Needham & Company LLCLower TargetBuy ➝ Buy$56.00 ➝ $50.00Low
8/10/2023JPMorgan Chase & Co.Lower TargetNeutral ➝ Neutral$46.00 ➝ $40.00Low
8/10/2023Deutsche Bank AktiengesellschaftLower Target$48.00 ➝ $37.00Low
8/10/2023WedbushReiterated RatingNeutral ➝ Neutral$45.00Low
8/10/2023BMO Capital MarketsLower TargetMarket Perform ➝ Market Perform$46.00 ➝ $41.00Low
8/10/2023Robert W. BairdLower Target$48.00 ➝ $44.00Low
8/10/2023CitigroupLower Target$42.00 ➝ $39.00Low
7/18/2023CitigroupDowngradeBuy ➝ Neutral$46.00 ➝ $42.00Low
5/15/2023Jefferies Financial GroupLower Target$47.00 ➝ $41.00Low
5/11/2023Robert W. BairdLower Target$54.00 ➝ $48.00Low
5/11/2023CitigroupLower Target$54.00 ➝ $46.00Low
2/13/2023CitigroupBoost TargetBuy$52.00 ➝ $54.00Low
2/10/2023Needham & Company LLCReiterated RatingBuy$56.00Low
2/8/2023BMO Capital MarketsBoost TargetMarket Perform$51.00 ➝ $53.00Low
12/15/2022JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$55.00 ➝ $50.00Low
11/10/2022BMO Capital MarketsLower TargetMarket Perform$57.00 ➝ $51.00Low
11/10/2022Robert W. BairdLower Target$56.00 ➝ $54.00Low
11/10/2022CitigroupLower TargetBuy$56.00 ➝ $52.00Low
10/14/2022JPMorgan Chase & Co.Lower TargetOverweight$62.00 ➝ $55.00Low
7/20/2022CitigroupLower TargetBuy$55.00 ➝ $52.00Low
5/6/2022Deutsche Bank AktiengesellschaftLower Target$55.00 ➝ $48.00High
2/14/2022CitigroupLower Target$62.00 ➝ $55.00Low
2/14/2022CowenDowngradeOutperform ➝ Market Perform$57.00 ➝ $51.00Low
1/26/2022Jefferies Financial GroupInitiated CoverageHold$54.00High
11/10/2021Deutsche Bank AktiengesellschaftBoost TargetHold$48.00 ➝ $55.00High
10/19/2021Robert W. BairdBoost TargetOutperform$58.00 ➝ $60.00High
8/17/2021JPMorgan Chase & Co.Boost TargetOverweight$55.00 ➝ $61.00Low
8/6/2021Needham & Company LLCBoost TargetBuy$54.00 ➝ $61.00Medium
5/11/2021Needham & Company LLCBoost TargetBuy$50.00 ➝ $54.00High
4/23/2021Robert W. BairdReiterated RatingBuy$54.00Low
2/10/2021Needham & Company LLCBoost TargetBuy$45.00 ➝ $50.00Low
11/3/2020BMO Capital MarketsLower TargetMarket Perform$48.00 ➝ $42.00High
11/3/2020Needham & Company LLCLower TargetBuy$48.00 ➝ $45.00High
8/17/2020JPMorgan Chase & Co.Boost TargetAverage ➝ Overweight$46.00 ➝ $52.00Low
8/7/2020Needham & Company LLCReiterated RatingBuy$48.00Medium
5/12/2020BMO Capital MarketsLower TargetMarket Perform$50.00 ➝ $41.00High
5/12/2020Deutsche Bank AktiengesellschaftLower TargetHold$44.00 ➝ $37.00High
5/12/2020Wells Fargo & CompanyBoost TargetOverweight$36.00 ➝ $39.00High
5/12/2020Robert W. BairdBoost TargetOutperform$42.00 ➝ $44.00High
5/12/2020Needham & Company LLCBoost TargetBuy$36.00 ➝ $40.00High
4/22/2020CitigroupLower TargetBuy$40.00 ➝ $37.00Low
4/19/2020JPMorgan Chase & Co.UpgradeNeutral ➝ OverweightLow
4/17/2020Wells Fargo & CompanyLower TargetOverweight$50.00 ➝ $36.00High
4/13/2020JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$39.00High
3/20/2020Needham & Company LLCReiterated RatingBuy$49.00 ➝ $36.00High
3/12/2020Needham & Company LLCLower TargetBuy$52.00 ➝ $49.00High
2/10/2020CowenBoost TargetOutperform$47.00 ➝ $49.00Low
2/7/2020William BlairReiterated RatingOutperformLow
2/7/2020CowenReiterated RatingBuy$47.00Low
2/7/2020Wells Fargo & CompanyBoost TargetOverweight$47.00 ➝ $50.00High
2/7/2020Cantor FitzgeraldBoost TargetOverweight$47.00 ➝ $50.00High
1/30/2020Robert W. BairdBoost TargetOutperform$50.00 ➝ $52.00Low
1/15/2020CitigroupBoost TargetBuy$47.00 ➝ $50.00Medium
1/9/2020Wells Fargo & CompanyBoost TargetOverweight$46.00 ➝ $47.00Low
11/8/2019Needham & Company LLCReiterated RatingBuy$48.00High
8/8/2019Deutsche Bank AktiengesellschaftBoost TargetHold$36.00 ➝ $44.00Low
8/8/2019Bank of AmericaBoost TargetBuy$40.00 ➝ $43.00High
8/8/2019WedbushBoost TargetNeutral$33.00 ➝ $45.00Low
8/8/2019Cantor FitzgeraldBoost TargetPositive ➝ Overweight$40.00 ➝ $47.00Low
8/8/2019Needham & Company LLCReiterated RatingBuy ➝ Buy$44.00 ➝ $48.00Low
7/16/2019WedbushReiterated RatingNeutralLow
6/14/2019Needham & Company LLCInitiated CoverageBuy ➝ BuyLow
(Data available from 5/24/2019 forward)

News Sentiment Rating

0.64 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 9 very positive mentions
  • 10 positive mentions
  • 4 negative mentions
  • 0 very negative mentions
10/27/2023
  • 6 very positive mentions
  • 12 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
11/26/2023
  • 11 very positive mentions
  • 10 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
12/26/2023
  • 14 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
1/25/2024
  • 26 very positive mentions
  • 22 positive mentions
  • 5 negative mentions
  • 2 very negative mentions
2/24/2024
  • 20 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/25/2024
  • 11 very positive mentions
  • 18 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
4/24/2024
  • 19 very positive mentions
  • 20 positive mentions
  • 3 negative mentions
  • 1 very negative mentions
5/24/2024

Current Sentiment

  • 19 very positive mentions
  • 20 positive mentions
  • 3 negative mentions
  • 1 very negative mentions
Genpact logo
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims. The Consumer and Healthcare segment provides demand generation, sensing and planning, supply chain planning and management, pricing and trade promotion management, deduction recovery management, order management, and digital commerce; and end-to-end claim lifecycle management, from claims processing and adjudication to claims recovery and payment integrity, revenue cycle management, health equity analytics, and care services. The High Tech and Manufacturing segment offers industry-specific solutions for trust and safety, advertising sales support, customer and user experience, and customer care support; and direct and indirect procurement, logistics, field, aftermarket support, and engineering services. It also provides digital operation services; data-tech-Al services; finance and accounting services, such as accounts payable, invoice-to-cash, record to report, financial planning and analysis, and enterprise risk and compliance; CFO advisory services; supply chain, and sourcing and procurement services; sales and commercial, and marketing and experience services; and environmental, social and governance services. The company was founded in 1997 and is based in Hamilton, Bermuda.
Read More

Today's Range

Now: $33.48
Low: $33.42
High: $33.97

50 Day Range

MA: $32.33
Low: $30.56
High: $34.46

52 Week Range

Now: $33.48
Low: $29.41
High: $39.75

Volume

486,836 shs

Average Volume

1,537,375 shs

Market Capitalization

$6.03 billion

P/E Ratio

9.57

Dividend Yield

1.78%

Beta

1.07

Frequently Asked Questions

What sell-side analysts currently cover shares of Genpact?

The following Wall Street sell-side analysts have issued stock ratings on Genpact in the last twelve months: BMO Capital Markets, Citigroup Inc., Deutsche Bank Aktiengesellschaft, JPMorgan Chase & Co., Mizuho, Needham & Company LLC, Robert W. Baird, StockNews.com, TheStreet, and Wedbush.
View the latest analyst ratings for G.

What is the current price target for Genpact?

8 Wall Street analysts have set twelve-month price targets for Genpact in the last year. Their average twelve-month price target is $38.00, suggesting a possible upside of 13.2%. JPMorgan Chase & Co. has the highest price target set, predicting G will reach $43.00 in the next twelve months. Citigroup Inc. has the lowest price target set, forecasting a price of $33.00 for Genpact in the next year.
View the latest price targets for G.

What is the current consensus analyst rating for Genpact?

Genpact currently has 1 sell rating, 5 hold ratings and 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in G, but not buy more shares or sell existing shares.
View the latest ratings for G.

What other companies compete with Genpact?

How do I contact Genpact's investor relations team?

Genpact's physical mailing address is 31 Victoria Street Victoria Place, Hamilton D0, HM 10. The business services provider's listed phone number is (441) 294-8000 and its investor relations email address is [email protected]. The official website for Genpact is www.genpact.com. Learn More about contacing Genpact investor relations.